GSK3B and amyotrophic lateral sclerosis: The treatment with lithium is able to alleviate the symptoms of ALS in human and animal cases by triggering autophagy through the GSK-3β pathway, and the collaboration of lithium and valproic acid (VPA) may have a better therapeutic effect on ALS [255, 256].